What is Fractyl Health, Inc. Common Stock's current stock price?

Fractyl Health, Inc. Common Stock (GUTS) currently trades at USD 0.4559. Track real-time price changes and historical performance on AllInvestView.

What sector is Fractyl Health, Inc. Common Stock in?

Fractyl Health, Inc. Common Stock operates in the Healthcare sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

Fractyl Health, Inc. Common Stock

🧾 Earnings Recap – Q3 2025

Fractyl Health achieved a significant milestone in Q3 2025 by demonstrating the efficacy of its Revita procedure in maintaining weight loss after the discontinuation of GLP-1 therapy, while also strengthening its financial position for upcoming clinical milestones.

Successfully reported randomized double-blind data indicating sustained weight loss in Revita-treated patients post-GLP-1 therapy, a critical advancement in obesity treatment.
Clinical programs are ahead of schedule, with over 60% of patient randomizations for the pivotal REMAIN one cohort completed.
Upcoming catalysts include six-month data from multiple cohorts and pivotal study results expected in 2026, positioning Revita for potential transformative impact in metabolic medicine.
Real-world studies further validate Revita's efficacy, showing significant weight loss and reductions in HbA1c in patients with type 2 diabetes over extended follow-up periods.

View full recap page

Fractyl Health, Inc. Common Stock Analysis (GUTS)

Is Fractyl Health, Inc. Common Stock a good investment? Fractyl Health, Inc. Common Stock (GUTS) is currently trading at 0.4559 USD. Market analysts have a consensus price target of 5.24 USD. This suggests a potential upside from current levels.

Earnings Schedule: Fractyl Health, Inc. Common Stock is expected to release its next earnings report on April 6, 2026. The market consensus estimate for Forward EPS is -0.57.

Investor FAQ

Does Fractyl Health, Inc. Common Stock pay a dividend?

No, it does not currently pay a dividend.

What asset class is Fractyl Health, Inc. Common Stock?

Fractyl Health, Inc. Common Stock is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be April 6, 2026. The company currently has a trailing EPS of -1.86.

Company Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Fractyl Health, Inc. Common Stock GUTS Open Fractyl Health, Inc. Common Stock in new tab

Fractyl Health, Inc. Common Stock

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features